pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,159 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07590934: Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Metastatic Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06648434: MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Sponsor: Washington University School of Medicine. Phase: PHASE1. Conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Cancer of the Pancreas

full page →ctgov ↗
›RECRUITINGphase readoutNCT06196034: Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma.

Sponsor: Chinese University of Hong Kong. Phase: . Conditions: Asthma

full page →ctgov ↗
›TERMINATEDphase readoutNCT05317364: Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery

Sponsor: University of Alabama at Birmingham. Phase: PHASE4. Conditions: Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence, Urinary Incontinence

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07381764: ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"

Sponsor: Gruppo Oncologico Italia Meridionale. Phase: PHASE2. Conditions: Metastatic Colorectal Cancer (CRC)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07446764: Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care

Sponsor: My Brother's Keeper, Inc.. Phase: NA. Conditions: HIV, STDs

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07362264: A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors

Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.. Phase: PHASE1. Conditions: Liver Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07480564: Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome

Sponsor: Taysha Gene Therapies, Inc.. Phase: PHASE3. Conditions: Rett Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07572409: Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory Study

Sponsor: manxiaxia. Phase: NA. Conditions: Ovarian Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06503809: Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›RECRUITINGphase readoutNCT07006532: Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

Sponsor: Shahid Beheshti University of Medical Sciences. Phase: NA. Conditions: Kidney Transplant Rejection

full page →ctgov ↗
›COMPLETEDphase readoutNCT05927532: Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study

Sponsor: Mozarc Medical US LLC. Phase: NA. Conditions: End Stage Renal Failure on Dialysis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07499232: A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Crohn Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07003698: Postoperative Analgesic Efficacy of Recto Intercostal Nerve Block

Sponsor: Ankara Etlik City Hospital. Phase: NA. Conditions: Laparoskopic Cholecystectomy, Recto Intercostal Nerve Block

full page →ctgov ↗
›RECRUITINGphase readoutNCT05169398: EUS-guided Hepatico-gastrostomy Using a Novel Lumen Apposing Metal Stent

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Malignant Biliary Obstruction

full page →ctgov ↗
›COMPLETEDphase readoutNCT04781621: Foundational Ingredients of Robotic Gait Training for People With Spinal Cord Injury During Inpatient Therapy

Sponsor: Baylor Research Institute. Phase: NA. Conditions: Spinal Cord Injuries

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03711214: Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome

Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Sjogren's Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04829604: ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Sponsor: Ambrx, Inc.. Phase: PHASE2. Conditions: HER2 Positive Metastatic Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05451004: SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

Sponsor: Canadian Cancer Trials Group. Phase: PHASE3. Conditions: Oropharyngeal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07286604: Ivermectin Repurposed for the Treatment of PKDL

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh. Phase: EARLY_PHASE1. Conditions: Post Kala Azar Dermal Leishmaniasis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05235204: Early Foley Catheter Removal After Diverticular Colovesical Fistula Repair

Sponsor: Karim Alavi. Phase: NA. Conditions: Colovesical Fistula

full page →ctgov ↗
›COMPLETEDphase readoutNCT04371484: Proposal of a Method Using the PMSI and SNIIRAM National Databases to Estimate the Frequency of Physical Abuse and to Identify th Eassociated At-risk Situations and Consequences in Children Aged 0 to 5 Years in France

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Child Abuse

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03921684: Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients

Sponsor: Baruch Brenner. Phase: PHASE2. Conditions: Rectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07319052: β-Alanine for Kickboxing Anaerobic Performance

Sponsor: Salih ÇABUK. Phase: NA. Conditions: Athletic Performance Enhancement (Kickboxing), Anaerobic Performance, Strength Endurance, Neuromuscular Power, Nutritional Supplementation (β-Alanine)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05610852: Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Sponsor: Case Comprehensive Cancer Center. Phase: NA. Conditions: Prostate Adenocarcinoma, Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06372249: A Clinical Trial of Soluble Fiber for Asthma

Sponsor: Phoenix Children's Hospital. Phase: PHASE2. Conditions: Asthma in Children

full page →ctgov ↗
›TERMINATEDphase readoutNCT05318638: Soft-robotic Glove Support of High-demand Tasks

Sponsor: Roessingh Research and Development. Phase: NA. Conditions: Neuromuscular Diseases, Sarcopenia

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06023238: Knee Prosthetic Joint Infection Antibiotic Elution

Sponsor: University of Pittsburgh. Phase: . Conditions: Prosthetic-joint Infection, Arthroplasty Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT07239258: The Effects of Mir Shakeel Teleintegrated Therapy Plan in Patients Undergoing Total Knee Arthroplasty

Sponsor: Lincoln University College. Phase: NA. Conditions: Total Knee Anthroplasty, Total Knee Arthroplasty Recovery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05757778: Split Chest Breast Neurotization

Sponsor: NYU Langone Health. Phase: NA. Conditions: Breast Implant; Complications

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07123285: Effect of Photobiomodulation on Healing of Venous Leg Ulcers

Sponsor: University of Nove de Julho. Phase: NA. Conditions: Venous Disease, Venous Insufficiency (Chronic)(Peripheral), Venous Insufficiency of Leg, Venous Leg Ulcer (VLU), Venous Leg Ulcer, Venous Hypertension Ulcers, Varicose Ulcers, Varicose Ulcer of Lower Limb

full page →ctgov ↗
›RECRUITINGphase readoutNCT05733585: Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair

Sponsor: IRCCS San Raffaele. Phase: . Conditions: Hemostatic

full page →ctgov ↗
›COMPLETEDphase readoutNCT07534085: Effects of a Structured Physical Activity Program on Balance and Functional Performance in Children With Down Syndrome

Sponsor: Ankara University. Phase: NA. Conditions: Down Syndrome (DS), Balance Assessment, Physical Activities, Yoga, Rehabilitation

full page →ctgov ↗
›RECRUITINGphase readoutNCT05806645: UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

Sponsor: University of Alberta. Phase: NA. Conditions: Acute Kidney Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07118345: Early Prophylactic Decompressive Hemicraniectomy Following Endovascular Therapy in Large Hemispheric Infarct Trial

Sponsor: Xuanwu Hospital, Beijing. Phase: NA. Conditions: Stroke, Ischemic, Cerebral Edema

full page →ctgov ↗
›RECRUITINGphase readoutNCT06578195: ASSESS ALL ALS Study

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix. Phase: . Conditions: Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT02526095: The French EsoGastricTumours Data Base

Sponsor: University Hospital, Lille. Phase: . Conditions: Esophageal Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07351695: Assessment of Nutritional Status Using Mid-Upper Arm Circumference Z-Score in Children With Cerebral Palsy

Sponsor: Muğla Sıtkı Koçman University. Phase: . Conditions: Cerebral Palsy (CP), Malnutrition in Children

full page →ctgov ↗
›RECRUITINGphase readoutNCT04888039: Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"

Sponsor: University Hospital, Toulouse. Phase: . Conditions: Multiple Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06603077: A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

Sponsor: Avalo Therapeutics, Inc.. Phase: PHASE2. Conditions: Hidradenitis Suppurativa

full page →ctgov ↗
›AVAILABLEphase readoutNCT07310277: Expanded Access to ABBV-706

Sponsor: AbbVie. Phase: . Conditions: Small Cell Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03049475: Pathophysiology of Acute Pain in Patients With Sickle Cell Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Sickle Cell Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07035275: Effect of Patient-Anesthesiologist Gender Concordance and Analgesia Method on Postoperative Pain in Mastectomy Patients

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Breast Cancer, Mastectomy, Postoperative Pain, Analgesic Use

full page →ctgov ↗
›RECRUITINGphase readoutNCT06315075: Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial

Sponsor: Haukeland University Hospital. Phase: NA. Conditions: Self-harm, Suicidal Ideation, Suicide and Self-harm

full page →ctgov ↗
›COMPLETEDphase readoutNCT06633757: Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance

Sponsor: ReCode Therapeutics. Phase: PHASE1. Conditions: Primary Ciliary Dyskinesia (PCD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07505212: Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals.

Sponsor: Prairie View A&M University. Phase: NA. Conditions: Obesity (Disorder)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05305781: Study of the Determinants of Emergency Dialysis in Reunion Island

Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: . Conditions: Dialysis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07583381: A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver Metastases

Sponsor: The First Hospital of Jilin University. Phase: NA. Conditions: Colorectal Liver Metastasis, Liver Neoplasms, Colorectal Neoplasms

full page →ctgov ↗
›RECRUITINGphase readoutNCT06513065: Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

Sponsor: University of Southampton. Phase: PHASE3. Conditions: Pseudomyxoma Peritonei

full page →ctgov ↗
›RECRUITINGphase readoutNCT05868265: A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Urothelial Carcinoma

full page →ctgov ↗
← prev
page 34 of 104
next →